Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share-based payments - Long-term Incentive Plan (Details)

v3.24.1.1.u2
Share-based payments - Long-term Incentive Plan (Details)
€ / shares in Units, € in Thousands
1 Months Ended 12 Months Ended
Dec. 29, 2023
€ / shares
Dec. 29, 2023
$ / shares
Aug. 10, 2023
May 24, 2023
€ / shares
May 24, 2023
$ / shares
Apr. 12, 2023
€ / shares
Apr. 12, 2023
$ / shares
May 31, 2023
shares
Dec. 31, 2023
EUR (€)
shares
associate
€ / shares
Dec. 31, 2023
shares
associate
$ / shares
Dec. 31, 2022
EUR (€)
shares
€ / shares
Dec. 31, 2021
EUR (€)
shares
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Number of shares reserved for issuance, per option (in shares)                 1 1    
Weighted average remaining contractual life of outstanding share options                 6 months      
Performance Options                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Vesting period                 3 years   2 years  
Granted during the period (in EUR per share) | € / shares                 € 0.12      
Number of shares reserved for issuance, per option (in shares)                 1 1    
Performance Options | Long-term Incentive Plan                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Granted during the period (in EUR per share) | € / shares                 € 0.12      
Number of plans | associate                 2 2    
Number of options exercisable (in shares)                     2,220,341 0
Number of share options expired in share-based payment arrangement (in shares)                 577,722   577,722  
Number of options exercisable (in shares)                 341,377 341,377 341,377  
Number of other equity instruments outstanding in share-based payment arrangement (in shares)                 723,384 723,384    
Weighted average remaining contractual life of outstanding share options                 7 years 7 months 13 days      
Share-based payment expenses - SPAC Transaction | €                 € 2,070   € 0 € 0
Performance Options | Long-term Incentive Plan | April 12, 2032                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Number of options exercisable (in shares)                 1,039,222 1,039,222    
Performance Options | Long-term Incentive Plan | April 12, 2033                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Number of options exercisable (in shares)                 1,758,841 1,758,841    
Performance Options 2022 | Long-term Incentive Plan                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Fair value of options granted (in EUR per share) | € / shares                 € 1.83   € 0  
Weighted average share price, share options granted (in EUR per share) | (per share)           € 1.95 $ 2.13          
Exercise price, share options granted (in EUR per share) | € / shares           € 0.12            
Performance Options 2023 | Long-term Incentive Plan                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Fair value of options granted (in EUR per share) | € / shares                 2.82   0  
Weighted average share price, share options granted (in EUR per share) | (per share)                 € 2.94 $ 3.14    
Exercise price, share options granted (in EUR per share) | € / shares                     € 0.12  
Equity Settled Awards                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Share-based payment expenses - SPAC Transaction | €                 € 19   € 0 0
LTIP Special Options | Long-term Incentive Plan                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Share-based payment expenses - SPAC Transaction | €                 € 972      
Fair value of options granted (in EUR per share) | (per share) € 1.22 $ 1.35             € 1.10   € 0  
Exercise price, share options granted (in EUR per share) | € / shares € 0.12                      
RSU                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Vesting period     1 year         3 years 3 years      
RSU | Long-term Incentive Plan                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Vesting period                 3 years      
Share-based payment expenses - SPAC Transaction | €                 € 1,729   € 0 € 0
Fair value of options granted (in EUR per share) | (per share)       € 1.97 $ 2.13       € 1.97   € 0  
RSU | Long-term Incentive Plan | Eligible directors                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Vesting period                 1 year      
Number of other equity instruments outstanding in share-based payment arrangement (in shares)               285,844     0  
RSU | Long-term Incentive Plan | Eligible directors | Awards Vesting On The Grant Date                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Share-based payment expenses - SPAC Transaction | €                 € 1,316      
RSU | Long-term Incentive Plan | Eligible directors | Award Vesting One Year From The Grant Date                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Share-based payment expenses - SPAC Transaction | €                 € 342      
RSU | Long-term Incentive Plan | Employees                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Number of other equity instruments outstanding in share-based payment arrangement (in shares)                 176,952 176,952 0  
Share-based payment expenses - SPAC Transaction | €                     € 70  
Bottom of range | Performance Options                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Vesting period                 2 years      
Top of range | Performance Options                        
Disclosure of terms and conditions of share-based payment arrangement [line items]                        
Vesting period                 3 years